David A. Spellman, SVP, CFO and Treasurer at Akebia Therapeutics, Inc. (AKBA), sold 7,539 shares at $0.81 ($6K) on 2023-02-27, disclosed to the SEC on 2023-03-01.
Open-market sale of $6k AKBA by SVP, CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AKBA | SELL | 2022-03-02 | $18K | — | Filing → |
| AKBA | SELL | 2021-04-01 | $3K | — | Filing → |